Stabilis Solutions (NASDAQ:SLNG - Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, November 6th. Investors that wish to register for the company's conference call can do so using this link.
Stabilis Solutions Stock Performance
SLNG traded down $0.14 during mid-day trading on Wednesday, reaching $4.36. 2,010 shares of the company traded hands, compared to its average volume of 5,165. The stock has a market capitalization of $81.03 million, a P/E ratio of 29.07 and a beta of 0.75. The company has a quick ratio of 1.63, a current ratio of 1.64 and a debt-to-equity ratio of 0.12. The company's fifty day moving average price is $4.34 and its 200-day moving average price is $4.16. Stabilis Solutions has a 52-week low of $3.77 and a 52-week high of $5.29.
Stabilis Solutions Company Profile
(
Get Free Report)
Stabilis Solutions, Inc, together with its subsidiaries, an energy transition company, provides clean energy production, storage, transportation, and fueling solutions primarily using liquefied natural gas (LNG) to various end markets in North America. The company offers LNG solutions to customers in aerospace, agriculture, energy, industrial, marine bunkering, mining, pipeline, remote power, and utility markets.
Further Reading
Before you consider Stabilis Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stabilis Solutions wasn't on the list.
While Stabilis Solutions currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
